PubRank

Zbigniew Rudzki

Author PubWeight™ 35.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med 2003 6.68
2 High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood 2002 3.93
3 Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood 2003 3.61
4 Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood 2008 2.80
5 The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood 2010 2.09
6 A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica 2008 1.63
7 Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations. Blood 2004 1.57
8 BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria. Clin Cancer Res 2007 1.50
9 Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Aust N Z J Obstet Gynaecol 2009 0.89
10 Validation of the multiplex ligation-dependent probe amplification (MLPA) technique for the determination of HER2 gene amplification in breast cancer. Diagn Mol Pathol 2011 0.87
11 Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain. Virchows Arch 2004 0.87
12 ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis. Leuk Res 2003 0.85
13 Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome. Arch Immunol Ther Exp (Warsz) 2008 0.85
14 The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology 2005 0.84
15 Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds. Clin Endocrinol (Oxf) 2008 0.84
16 Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene. Br J Haematol 2002 0.84
17 Pure red cell aplasia due to treatment with epoietin beta: first case report of PRCA from Poland. Przegl Lek 2006 0.82
18 Sarcoma and familial retinoblastoma. Clin Experiment Ophthalmol 2003 0.81
19 Haemorrhagic colitis caused by dasatinib. Case Rep Hematol 2012 0.80
20 Preimplantation genetic diagnosis for beta-thalassaemia using sequencing of single cell PCR products to detect mutations and polymorphic loci. Mol Hum Reprod 2002 0.79
21 CDX-2 expression is reduced in colorectal carcinomas with solid growth pattern and proximal location, but is largely independent of MSI status. Pol J Pathol 2004 0.77
22 The JAK2 V617F mutation is frequently present in buccal swabs from patients suffering from Philadelphia-negative chronic myeloproliferative disorders, who carry the mutation detected in bone marrow or peripheral blood cells [corrected]. J Clin Pathol 2007 0.75
23 High prevalence of non-Hodgkin's lymphomas in Polish population--1106 new cases diagnosed according to WHO classification in only one district. Pol J Pathol 2006 0.75
24 EBV-positive gastric carcinomas in Poland. Pol J Pathol 2003 0.75
25 Splenic tumors in an adult with tuberous sclerosis: the giant "histiocytoid" cells are dysplastic histiocytes. Virchows Arch 2005 0.75
26 Idiopathic myelofibrosis with fatty bone marrow: an issue of sampling? A propos an unusual case. Haematologica 2003 0.75
27 [Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up]. Przegl Lek 2011 0.75
28 Clonal lymphocytic populations in Philadelphia-negative chronic myeloproliferative disorders: is the T-cell clonality of 'undetermined' significance (TCUS) linked to a worse clinical outcome? Leuk Lymphoma 2006 0.75
29 A low-grade follicular lymphoma with strong expression of cyclin D1, but without evidence of CCND1 translocation or amplification. J Clin Pathol 2013 0.75
30 [Concomitant myeloid sarcoma and plasma cell myeloma--case report of a hitherto undescribed association of two neoplasms]. Pol Merkur Lekarski 2007 0.75